Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma.
Current antiviral therapy fails to clear infection in a substantial proportion of cases. Drug …

Objective Hepatitis C virus (HCV) infection causes severe liver disease and affects more
than 160 million individuals worldwide. People undergoing liver organ transplantation face …

Antiviral drugs targeting viral proteins often result in prompt selection for resistance. Moreover,
the number of viral targets is limited. Novel antiviral targets are therefore needed. The …

Primary attachment to cellular glycans is a critical entry step for most human viruses. Some
viruses, such as herpes simplex virus type 1 (HSV-1) and hepatitis C virus (HCV), bind to …

Several observations indicate that late-G 1 /S-phase-specific cellular functions may be required
for herpes simplex virus (HSV) replication: (i) certain mutant HSV strains are replication …

Pharmacological cyclin-dependent kinase (cdk) inhibitors (PCIs) block replication of several
viruses, including herpes simplex virus type 1 (HSV-1) and human immunodeficiency virus …

We have analysed the COVID-19 epidemic data of more than 174 countries (excluding
China) in the period between 22 January and 28 March 2020. We found that some countries (…

The advent of flow cytometry-based applications has significantly impacted the study of
cellular apoptosis. Propidium iodide (PI) is a commonly used viability stain in these studies. …

Hepatitis C virus (HCV) is a positive‐strand RNA virus that primarily infects human hepatocytes.
Infections with HCV constitute a global health problem, with 180 million people currently …

Cyclin-dependent kinases (cdks) are required for replication of viruses that replicate only in
dividing cells, such as adeno- and papillomaviruses. Recently, cdks have been shown to be …